— Updates, insights, and discussions on cancer-related topics The FDA has broadened the approval for dostarlimab (Jemperli), now allowing its use alongside chemotherapy for treating patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient or microsatellite stable tumors. A recent survey in the journal Menopause highlighted that 37% of women are unaware that postmenopausal bleeding is a critical indicator of endometrial cancer. In another

— Pilot Study Paves the Way for Larger Trials on Brain Health Assessment PHILADELPHIA -- In a preliminary investigation, intermittent calorie restriction improved executive function and memory in older adults without cognitive impairments. This 8-week randomized study involved 40 overweight, cognitively healthy seniors with insulin resistance. Researchers compared two dietary strategies: a 5:2 intermittent fasting approach versus a “healthy living” diet, which followed USDA guidelines on